← Back to Events
Tier 1 Global Networking: High IMMUNOLOGY CONCLUDED
EULAR 2026 — Not specified, London, UK
The EULAR 2026 Congress will take place at the Excel London from Wednesday, 3 June to Saturday, 6 June 2026. Our organising committee have created a .
5,000+ Attendees
5 Presentations
3 Companies
2 Drugs
Presentation data updated Jun 5, 2026, 8:41 AM UTC
Nova Event Impact Score
50 /100
- Media coverage 10/20
- Speaker quality 20/20
- Pipeline relevance 1/20
- Historical influence 13/20
- Company participation 6/20
Key Takeaways
Key Themes
immunologyEuropean League Against Rheumatism (EULAR)Pipeline announcementsPartnership deals
Key Companies
AmgenUCBNovartis
Key Drugs
inebilizumabbimekizumab
Key Markets
Europe
Key Opportunities
Partnership dealsLicensing discussionsVendor selection
Investors & analysts
bimekizumab at EULAR 2026
ORAL Jun 3
OP0185
Treatment retention and clinical remission in 787 real-world patients with psoriatic arthritis treated with bimekizumab